Ocular Therapeutix Inc (OCUL)

EV/EBITDA

-3.31×

TTM · Retrieved:

OCUL logo

OCUL EV/EBITDA

Current (TTM)-3.31×
OCUL Quarterly EV/EBITDA (-20.40× → -22.80×)
High-resolution chart · PNG

OCUL ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc EV/EBITDA — Quarterly
Period endingEV/EBITDA
-22.7978×
-15.5039×
-33.7792×
-28.8041×
-20.1889×
-16.1134×
-25.2321×
-34.0682×
-18.16×
-12.3384×
-14.9312×
58.3421×
-22.2235×
-14.0168×
-13.5097×
-11.7995×
-14.1372×
-28.509×
-268.022×
131.3853×
-152.6815×
201.1672×
-15.5265×
-48.8195×
-13.2474×
-14.0448×
-8.3447×
-8.1546×
-8.697×
-9.9098×
-8.1665×
-16.7504×
-16.5913×
-14.016×
-8.9753×
-10.0393×
-12.5248×
-14.3332×
-15.7209×
-14.9723×
-8.2477×
-20.211×
-21.4625×
-29.2721×
-42.6053×
-129.5887×
-64.7702×
-23.7475×
-5.8479×
-3.9084×
-5.9161×
0×
0×
-20.3973×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.